2026 Interventional Neurology Reading List

Reading List

Please click below to access the 2026 Interventional Neurology reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Apply the current and latest knowledge of potential indications for thrombectomy in proximal LVO of the anterior circulation presenting with large-core infarct
• Apply the latest guideline recommendations for MMA embolization for CSH
• Apply the latest knowledge for the indication of and the technical nuances of flow diverters for treatment of cerebral aneurysm
• Discuss new endovascular methods for managing CSF venous fistulae
• Differentiate the benefits/risks of transradial cerebral angiography

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2026 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Interventional Neurology Certification Examination Committee Contributors

Alberto Maud, MD, Chair, Texas Tech Health Science Center El Paso 
Disclosures: Nothing to disclose. 

Nazli A. Janjua, MD, Vice Chair, Asia Pacific Comprehensive Stroke Institute 
Disclosures: Nothing to disclose. 

Norman Ajiboye, MD, Memorial Healthcare System 
Disclosures: Nothing to disclose. 

Steve Mario Cordina, MD, Patronus Neurology 
Disclosures: Nothing to disclose. 

Mesha Martinez, MD, Texas Children's - Baylor College of Medicine 
Disclosures: Received compensation: Cerenovus- Consultant (self), Siemens- Consultant (self), RapidAI- Consultation (self). Received compensation from Microvention- data safety monitoring board (self). Received compensation from Bendin, Sumrall, and Ladner, LLC as an expert witness. 

Camilo R. Gomez, MD, MBA, University of Missouri Medical Center 
Disclosures: Nothing to disclose. 

Osman S. Kozak, MD, Abington Memorial Hospital 
Disclosures: Nothing to disclose. 

Janhavi Modak, MD, Baystate Medical Center  
Disclosures: Has multiple stock holdings in the personal investment portfolio. Spouse holds patents, not directly related to healthcare. 

Thanh Nguyen, MD, Boston University Medical Center  
Disclosures: Received compensation as a consultant for Medtronic. Received compensation for serving on advisory board: Brainomix, Bayer DSMB: CREST2. Received compensation as a speaker for Genentech and Kaneka. Received compensation as the associate editor for Stroke. Non-compensated role serving as SVIN President. 

Santiago Ortega Gutierrez, MD, University of Iowa Hospitals and Clinics  
Disclosures: Received compensation for serving as a consultant from Medtronic and Stryker. Received compensation for serving on a speaker’s bureau for Medtronic and Stryker. Received compensation for serving as a board member of Society of Vascular and Interventional Neurology. Owns stock/has ownership interest in Eureka (15%).  

Jefferson T. Miley, MD, University of Texas at Austin  
Disclosures: Nothing to disclose.  

Pankajavalli Ramakrishnan, MD, PhD, MidHudson Regional Hospital  
Disclosures: Nothing to disclose.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326